Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Jauslin, Petra M
~ 0  Ergebnisse:
Personensuche X
?
1

Exposure–Response Analyses for Belzutifan to Inform Dosing ..:

Marathe, Dhananjay D. ; Jauslin, Petra M. ; Jan Kleijn, Huub...
The Journal of Clinical Pharmacology.  , 2024
Link: https://doi.org/10.1002/..
 
?
2

Population pharmacokinetic analyses for belzutifan to infor..:

Marathe, Dhananjay D. ; Jauslin, Petra M. ; Kleijn, Huub Jan...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  10 - p. 1499-1510 , 2023
Link: https://doi.org/10.1002/..
 
?
3

Exposure–response characterisation of tildrakizumab in chro..:

Kerbusch, Thomas ; Li, Hanbin ; Wada, Russell..
British Journal of Clinical Pharmacology.  86 (2020)  9 - p. 1795-1806 , 2020
Link: https://doi.org/10.1111/..
 
?
4

Identification of the Mechanism of Action of a Glucokinase ..:

Jauslin, Petra M. ; Karlsson, Mats O. ; Frey, Nicolas
The Journal of Clinical Pharmacology.  52 (2012)  12 - p. 1861-1871 , 2012
Link: https://doi.org/10.1177/..
 
?
5

Modeling of 24-Hour Glucose and Insulin Profiles of Patient..:

Jauslin, Petra M. ; Frey, Nicolas ; Karlsson, Mats O.
The Journal of Clinical Pharmacology.  51 (2011)  2 - p. 153-164 , 2011
Link: https://doi.org/10.1177/..
 
?
6

An Integrated Model for the Glucose‐Insulin System:

Silber, Hanna E. ; Jauslin, Petra M. ; Frey, Nicolas.
Basic & Clinical Pharmacology & Toxicology.  106 (2010)  3 - p. 189-194 , 2010
Link: https://doi.org/10.1111/..
 
?
7

An Integrated Glucose‐Insulin Model to Describe Oral Glucos..:

Jauslin, Petra M. ; Silber, Hanna E. ; Frey, Nicolas...
The Journal of Clinical Pharmacology.  47 (2007)  10 - p. 1244-1255 , 2007
Link: https://doi.org/10.1177/..
 
?
8

An Integrated Model for Glucose and Insulin Regulation in H..:

Silber, Hanna E. ; Jauslin, Petra M. ; Frey, Nicolas...
The Journal of Clinical Pharmacology.  47 (2007)  9 - p. 1159-1171 , 2007
Link: https://doi.org/10.1177/..
 
?
9

Population pharmacokinetic analyses for belzutifan to infor..:

Marathe, Dhananjay D ; Jauslin, Petra M ; Kleijn, Huub Jan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583240/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Exposure–response characterisation of tildrakizumab in chro..:

Kerbusch, Thomas ; Li, Hanbin ; Wada, Russell..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444761/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
11

Population pharmacokinetic analyses for belzutifan to infor..:

Dhananjay D. Marathe ; Petra M. Jauslin ; Huub Jan Kleijn...
https://doi.org/10.1002/psp4.13028.  , 2023
Link: https://doi.org/10.1002/..
 
?
12

Population Pharmacokinetics and Exposure–Response Analysis ..:

He, Jimmy Zhijian ; Duval, Vincent ; Jauslin, Petra...
Clinical Pharmacology & Therapeutics.  114 (2023)  6 - p. 1375-1386 , 2023
Link: https://doi.org/10.1002/..
 
?
13

Pharmacometric analysis linking immunoglobulin exposure to ..:

Tortorici, Michael A. ; Yuraszeck, Theresa ; Cornblath, David...
CPT: Pharmacometrics & Systems Pharmacology.  10 (2021)  8 - p. 839-850 , 2021
Link: https://doi.org/10.1002/..
 
?
14

Population-Pharmacokinetic Modeling of Tildrakizumab (MK-32..:

Jauslin, Petra ; Kulkarni, Pooja ; Li, Hanbin...
Clinical Pharmacokinetics.  58 (2019)  8 - p. 1059-1068 , 2019
Link: https://doi.org/10.1007/..
 
?
15

A cellular model for Friedreich Ataxia reveals small-molecu..:

Jauslin, M. L.
Human Molecular Genetics.  11 (2002)  24 - p. 3055-3063 , 2002
Link: https://doi.org/10.1093/..
 
1-15